Life Sciences & Healthcare

In this report, Project HOPE and Deloitte US have brought together frontline healthcare workers, programme leaders, health system advisors, policy and advocacy professionals, community leaders and strategic relationships to collaborate on potential solutions for enhancing climate resilience.

Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.

Deloitte's Electronic Health Record (EHR) solution helps health systems execute digital transformation that shifts legacy models into modern best practices anchored on elevating the human experience.

With the global pandemic firmly in the rearview mirror, life sciences companies are looking at key macro- and micro-economic drivers to guide their future growth.

The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalised vaccine manufacturing ecosystems. This approach aims to revolutionise vaccine production and distribution, promoting equity and resilience in the face of future health crises.

From digital health to biotech and from digital therapeutics to healthcare IT innovations, there’s a community and a conversation about it at HLTH Europe Events.

Measuring the return from pharmaceutical innovation - 14th edition

The global healthcare sector is undergoing a period of unprecedented transformation, driven by technological advancements, demographic shifts and evolving patient needs. In 2024, several key trends are poised to shape the future of healthcare delivery. How can sector leaders and stakeholders prepare themselves for this profound change?

Deloitte is honoured to be one of a growing list of 60+ signatories of the Zero Health Gaps Pledge, the first global, multi-sector, CEO-level pledge to help advance health equity.

Learn more about the specific actions the Deloitte Health Equity Institutes are taking to foster health equity for all.

The critical success factors identified in 2020 remain paramount. But now stakeholders need to act on the lessons learnt to strengthen the collective ability to respond to or—better yet—proactively address the existing global health Issue.

A Deloitte and World Economic Forum report